Kamel, A.S.; Mohamed, A.F.; Rabie, M.A.; Elsherbiny, M.E.; Ahmed, K.A.; Khattab, M.M.; Abdelkader, N.F.
Correction: Kamel et al. Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors. Pharmaceuticals 2022, 15, 251. Pharmaceuticals 2025, 18, 645.
https://doi.org/10.3390/ph18050645
AMA Style
Kamel AS, Mohamed AF, Rabie MA, Elsherbiny ME, Ahmed KA, Khattab MM, Abdelkader NF.
Correction: Kamel et al. Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors. Pharmaceuticals 2022, 15, 251. Pharmaceuticals. 2025; 18(5):645.
https://doi.org/10.3390/ph18050645
Chicago/Turabian Style
Kamel, Ahmed S., Ahmed F. Mohamed, Mostafa A. Rabie, Marwa E. Elsherbiny, Kawkab A. Ahmed, Mahmoud M. Khattab, and Noha F. Abdelkader.
2025. "Correction: Kamel et al. Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors. Pharmaceuticals 2022, 15, 251" Pharmaceuticals 18, no. 5: 645.
https://doi.org/10.3390/ph18050645
APA Style
Kamel, A. S., Mohamed, A. F., Rabie, M. A., Elsherbiny, M. E., Ahmed, K. A., Khattab, M. M., & Abdelkader, N. F.
(2025). Correction: Kamel et al. Experimental Evidence for Diiodohydroxyquinoline-Induced Neurotoxicity: Characterization of Age and Gender as Predisposing Factors. Pharmaceuticals 2022, 15, 251. Pharmaceuticals, 18(5), 645.
https://doi.org/10.3390/ph18050645
